(Q28374416)

The spectrum of drug-induced pulmonary disease

ChEBI release 2020-05-28

1 reference

M Hassan

1

0 references

language of work or name

English

0 references

publication date

September 1999

0 references

published in

Medical Oncology

0 references

volume

16

0 references

issue

3

0 references

page(s)

166-76

0 references

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02906128

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02906128

Busulfan and veno-occlusive disease of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02906128

High-dose busulfan and myoclonic epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02906128

High-dose busulfan and seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02906128

Metabolism of 14C-busulfan in isolated perfused rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02906128

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02906128

Anticonvulsants and busulfan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02906128

21 January 2018

Busulphan and phenytoin

1 reference

https://api.crossref.org/works/10.1007%2FBF02906128

Busulfan pharmacokinetics using a single daily high-dose regimen in children with acute leukemia

21 January 2018

1 reference

12 December 2020

Quantitation of busulfan in plasma by high-performance liquid chromatography using postcolumn photolysis

1 reference

12 December 2020

Quantitation of busulfan in plasma by high-performance liquid chromatography

1 reference

12 December 2020

Urinary metabolites of busulfan in the rat.

1 reference

12 December 2020

In vivo distribution of [11C]-busulfan in cynomolgus monkey and in the brain of a human patient.

1 reference

12 December 2020

Cataract after busulphan treatment.

1 reference

12 December 2020

Preparative regimens for marrow transplantation containing busulphan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis

1 reference

12 December 2020

Acute toxicity and first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia

1 reference

12 December 2020

High dose busulfan and seizures

1 reference

12 December 2020

Allogeneic bone marrow transplantation after high-dose busulfan and cyclophosphamide in patients with acute nonlymphocytic leukemia

1 reference

12 December 2020

Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapy

1 reference

12 December 2020

Gas chromatographic determination of busulfan in plasma with electron-capture detection

1 reference

12 December 2020

Determination of busulfan in plasma by GC-MS with selected-ion monitoring

1 reference

12 December 2020

Chemotherapeutic agents and hepatotoxicity

1 reference

12 December 2020

Hepatic veno-occlusive disease--liver toxicity syndrome after bone marrow transplantation

1 reference

12 December 2020

The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantation

1 reference

12 December 2020

Busulphan treatment of polycythaemia vera

1 reference

12 December 2020

Polycythemia vera treated with -32p and myleran: development of chronic granulocytic leukemia with chromosomal abnormalities in one patient

1 reference

12 December 2020

[Therapeutic considerations in chronic myeloid leukemia]

1 reference

12 December 2020

Big BU/CY is associated with a favorable long-term outcome in patients allotransplanted for chronic myelogenous leukemia in chronic phase

1 reference

12 December 2020

Liposomal busulphan: bioavailability and effect on bone marrow in mice

1 reference

12 December 2020

Measurement of busulfan in plasma by high-performance liquid chromatography

1 reference

12 December 2020

Is 600 mg/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation?

1 reference

12 December 2020

Busulphan kinetics and limited sampling model in children with leukemia and inherited disorders

1 reference

12 December 2020

Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.

1 reference

12 December 2020

Association of busulfan area under the curve with veno-occlusive disease following BMT.

1 reference

12 December 2020

Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study

1 reference

12 December 2020

The possibility of radical chemotherapy in chronic myelocytic leukaemia

1 reference

12 December 2020

Metabolic fate of tritiated busulfan in man

1 reference

12 December 2020

High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients

1 reference

12 December 2020

Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osse

1 reference

12 December 2020

Preliminary results of high-dose busulfan and cyclophosphamide with syngeneic or autologous bone marrow rescue

1 reference

12 December 2020

The impact of marrow transplant preparative regimens on subsequent growth and development. The Seattle Marrow Transplant Team

1 reference

12 December 2020

High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin's lymphoma

1 reference

12 December 2020

Busulfan-glutathione conjugation catalyzed by human liver cytosolic glutathione S-transferases

1 reference

12 December 2020

Bone-marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968-1985

1 reference

12 December 2020

Busulfan bioavailability.

1 reference

12 December 2020

Disposition of high-dose busulfan in pediatric patients undergoing bone marrow transplantation

1 reference

12 December 2020

Determination of busulfan in human plasma by gas chromatography with electron-capture detection

1 reference

12 December 2020

Busulfan and total body irradiation as antihematopoietic stem cell agents in the preparation of patients with congenital bone marrow disorders for allogenic bone marrow transplantation

1 reference

12 December 2020

A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group

1 reference

12 December 2020

Clinical and morphological side-effects of busulfan (Myleran) treatment

1 reference

12 December 2020

Identification and quantitative determination of four different mercapturic acids formed from 1,3-dibromopropane and its 1,1,3,3-tetradeutero analogue by the rat

1 reference

12 December 2020

Convulsions due to high-dose busulphan

1 reference

12 December 2020

Pharmacokinetic and metabolic studies of high-dose busulphan in adults

1 reference

12 December 2020

Formulation and stability of busulfan for intravenous administration in high-dose chemotherapy

1 reference

12 December 2020

Gas-chromatographic analysis of busulfan for therapeutic drug monitoring

1 reference

12 December 2020

Daily rhythmic variation and liver drug metabolism in rats

1 reference

12 December 2020

Myleran in chronic myeloid leukaemia; chemical constitution and biological action

1 reference

12 December 2020

Age-dependent tetrahydrothiophenium ion formation in young children and adults receiving high-dose busulfan

1 reference

12 December 2020

Busulfan disposition: the role of therapeutic monitoring in bone marrow transplantation induction regimens

1 reference

12 December 2020

Gas chromatographic-mass spectrometric assay for busulfan in biological fluids using a deuterated internal standard

1 reference

12 December 2020

High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study

1 reference

12 December 2020

Pharmacokinetics of intravenous busulfan and evaluation of the bioavailability of the oral formulation in conditioning for haematopoietic stem cell transplantation

1 reference

12 December 2020

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

1 reference

12 December 2020

Stage IV neuroblastoma in patients over 1 year of age at diagnosis: consolidation of poor responders with combined busulfan, cyclophosphamide and melphalan followed by in vitro mafosfamide-purged autologous bone marrow transplantation

1 reference

12 December 2020

Degradation of busulfan in aqueous solution

1 reference

12 December 2020

Primary thrombocythaemia treated with busulphan

1 reference

12 December 2020

High-dose chemotherapy with autologous bone marrow support as consolidation after standard-dose adjuvant therapy in primary breast cancer patients with seven or more involved axillary lymph nodes

1 reference

12 December 2020

Glutathione S-transferases catalyzed conjugation of 1,4-disubstituted butanes with glutathione in vitro

1 reference

12 December 2020

Pretransplant conditioning with busulfan (Myleran) and cyclophosphamide for nonmalignant diseases. Assessment of engraftment following histocompatible allogeneic bone marrow transplantation

1 reference

12 December 2020

Busulfan pharmacokinetics in bone marrow transplant patients: is drug monitoring warranted?

1 reference

12 December 2020

More on high-dose busulfan and seizure prophylaxis

1 reference

12 December 2020

Pharmacokinetics and distribution of liposomal busulfan in the rat: a new formulation for intravenous administration

1 reference

12 December 2020

Busulfan disposition below the age of three: alteration in children with lysosomal storage disease

1 reference

12 December 2020

Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation

1 reference

12 December 2020

Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology

1 reference

12 December 2020

Twenty-five year survival of chronic granulocytic leukaemia with spontaneous karyotype conversion

1 reference

12 December 2020

4-Methanesulfonyloxybutanol: hydrolysis of busulfan

1 reference

12 December 2020

Cerebrospinal fluid and plasma concentrations of busulfan during high-dose therapy

1 reference

12 December 2020

Busulfan concentration in relation to permanent alopecia in recipients of bone marrow transplants

1 reference

12 December 2020

Preliminary studies on the distribution and fate of TEM, TEPA, and myleran in the human

1 reference

12 December 2020

Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics.

1 reference

12 December 2020

Pharmacokinetics of high-dose busulfan in children

1 reference

12 December 2020

Venoocclusive disease of the liver following bone marrow transplantation

1 reference

12 December 2020

High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer

1 reference

12 December 2020

Frequency of veno-occlusive disease of the liver in bone marrow transplantation with a modified busulfan/cyclophosphamide preparative regimen

1 reference

12 December 2020

Pulmonary lesions associated with busulfan therapy of chronic myelogenous leukemia

1 reference

12 December 2020

Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation

1 reference

12 December 2020

Use of a water-soluble busulfan formulation--pharmacokinetic studies in a canine model

1 reference

12 December 2020

Treatment of myelodysplastic syndrome with busulfan-cyclophosphamide conditioning followed by allogeneic BMT

1 reference

12 December 2020

Busulfan and cyclophosphamide (BU/CY2) as preparative regimen for patients with lymphoma

1 reference

12 December 2020

Determination of busulfan in plasma by high-performance liquid chromatography

1 reference

12 December 2020

Marrow transplantation for thalassaemia following busulphan and cyclophosphamide

1 reference

12 December 2020

Treatment of polycythemia vera

1 reference

12 December 2020

A randomized trial comparing busulfan vs total body irradiation in allogeneic marrow transplant recipients with hematological malignancies

1 reference

12 December 2020

The effect of hepatic enzyme inducers on busulfan neurotoxicity and myelotoxicity

1 reference

12 December 2020

Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation

1 reference

12 December 2020

Busulfan (Bu) and cyclophosphamide (Cy) for marrow transplantation

1 reference

12 December 2020

High-performance liquid chromatographic-mass spectrometric assay of busulfan in serum and cerebrospinal fluid

1 reference

12 December 2020

Diurnal variations in the transferases and hydrolases involved in glucuronide and sulfate conjugation of rat liver

1 reference

12 December 2020

Comparison of human liver and small intestinal glutathione S-transferase-catalyzed busulfan conjugation in vitro

1 reference

12 December 2020

Chemotherapy of chronic myelocytic leukemia

1 reference

12 December 2020

Effect of Busulfan on Oncornavirus-Like Activity in Platelets and Chromosomes in Polycythemia Vera and Essential Thrombocythemia 2

1 reference

12 December 2020

Busulphan and bone marrow depression.

1 reference

12 December 2020

Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia

1 reference

12 December 2020

A case of pulmonary alveolar proteinosis complicating chronic myelogenous leukemia. A peculiar pathologic aspect of busulfan lung?

1 reference

12 December 2020

Pharmacologically-guided dose adjustment of busulfan in high-dose chemotherapy regimens: rationale and pitfalls (review).

1 reference

12 December 2020

An improved limited sampling method for individualised busulphan dosing in bone marrow transplantation in children

1 reference

12 December 2020

Growth retardation and depigmentation of hair after high-dose busulfan and congenic hematopoietic cell transplantation in mice

1 reference

12 December 2020

Cytogenetic effects of myleran in vivo on bone-marrow cells from male mice

1 reference

12 December 2020

Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children

1 reference

12 December 2020

Busulfan-induced pulmonary disease. Report of a case and review of the literature

1 reference

12 December 2020

Busulfan disposition in children

1 reference

12 December 2020

The chemical and biological properties of busulphan ("Myleran").

1 reference

12 December 2020

Pharmacokinetic and metabolic studies of busulfan in rat plasma and brain

1 reference

12 December 2020

Temporal variations in microsomal lipid peroxidation and in glutathione concentration of rat liver

1 reference

12 December 2020

Binding of busulfan to plasma proteins and blood cells

1 reference

12 December 2020

Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo)

1 reference

12 December 2020

Intermediate-dose busulfan and cyclophosphamide as a conditioning regimen for bone marrow transplantation in a case of Fanconi anemia in myelodysplastic transformation

1 reference

12 December 2020

Current Concepts in the Treatment of Chronic Myelocytic Leukemia

1 reference

12 December 2020

Busulfan lung. Pulmonary fibrosis caused by Myleran

1 reference

12 December 2020

Chronopharmacology of high-dose busulfan in children

1 reference

12 December 2020

Engraftment rates related to busulphan and cyclophosphamide dosages for displacement bone marrow transplants in fifty children

1 reference

12 December 2020

Therapeutic monitoring of busulfan in hematopoietic stem cell transplantation

1 reference

12 December 2020

Delayed toxic effect of busulfan on the marrow

1 reference

12 December 2020